DOI QR코드

DOI QR Code

Percutaneous Extracorporeal Membrane Oxygenation for Graft Dysfunction after Heart Transplantation

  • Lim, Jae Hong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Hwang, Ho Young (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Yeom, Sang Yoon (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Cho, Hyun-Jai (Division of Cardiology, Department of Internal Medicine, Cardiovascular Center and Cardiovascular Research Institute, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Lee, Hae-Young (Division of Cardiology, Department of Internal Medicine, Cardiovascular Center and Cardiovascular Research Institute, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Ki-Bong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2013.07.31
  • Accepted : 2013.10.10
  • Published : 2014.04.05

Abstract

Background: We evaluated the safety and efficacy of percutaneous extracorporeal membrane oxygenation (ECMO) in patients with primary graft dysfunction after heart transplantation. Methods: Of 65 patients (44 males and 21 females) who underwent heart transplantation from January 2006 to December 2012, 13 patients (group I) needed peripheral ECMO support due to difficulty in weaning from cardiopulmonary bypass (CPB) and 52 patients (group II) were weaned from CPB without mechanical support. The mean age of the patients at the time of operation was $54.4{\pm}13.6$ years. There were no differences in the preoperative characteristics of the two groups. Multivariable analysis was performed to identify the risk factors for ECMO therapy. Results: All group I patients were successfully weaned from ECMO after $53{\pm}9$ hours of circulatory support. Early mortality occurred in four patients (1 [7.7%] in group I and 3 [5.8%] in group II, p>0.999). There were no differences in the postoperative complications between the two groups, with the exception of reoperation for bleeding. A greater number of group I patients underwent reoperation for bleeding (5 [38.5%] in group I vs. 6 [11.5%] in group II, p=0.035). In multivariable analysis, preoperative mechanical support (ECMO and intra-aortic balloon pump) and longer CPB time were the risk factors of ECMO therapy for graft dysfunction (odds ratio, 6.377; 95% confidence interval, 1.519 to 26.77; p=0.011 and odds ratio, 1.010; 95% confidence interval, 1.001 to 1.019; p=0.033). Conclusion: Percutaneous ECMO support could be a viable option for rescuing patients when graft dysfunction refractory to medical management develops after heart transplantation.

Keywords

References

  1. Taghavi S, Zuckermann A, Ankersmit J, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg 2004;78:1644-9. https://doi.org/10.1016/j.athoracsur.2004.04.059
  2. Taghavi S, Ankersmit HJ, Wieselthaler G, et al. Extracorporeal membrane oxygenation for graft failure after heart transplantation: recent Vienna experience. J Thorac Cardiovasc Surg 2001;122:819-20. https://doi.org/10.1067/mtc.2001.115692
  3. Marasco SF, Vale M, Pellegrino V, et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Thorac Surg 2010;90:1541-6. https://doi.org/10.1016/j.athoracsur.2010.05.066
  4. Sung K, Lee YT, Park PW, et al. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg 2006;82:651-6. https://doi.org/10.1016/j.athoracsur.2006.03.017
  5. Lee WS, Chee HK, Song MG, et al. Short-term mechanical circulatory support with a centrifugal pump: results of peripheral extracorporeal membrane oxygenator according to clinical situation. Korean J Thorac Cardiovasc Surg 2011;44:9-17. https://doi.org/10.5090/kjtcs.2011.44.1.9
  6. Mihaljevic T, Jarrett CM, Gonzalez-Stawinski G, et al. Mechanical circulatory support after heart transplantation. Eur J Cardiothorac Surg 2012;41:200-6.
  7. D'Alessandro C, Golmard JL, Barreda E, et al. Predictive risk factors for primary graft failure requiring temporary extra- corporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg 2011;40:962-9.
  8. D'Alessandro C, Aubert S, Golmard JL, et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. Eur J Cardiothorac Surg 2010;37:343-9.
  9. Marasco SF, Esmore DS, Negri J, et al. Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant 2005;24:2037-42. https://doi.org/10.1016/j.healun.2005.06.007
  10. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008. J Heart Lung Transplant 2008;27:943-56. https://doi.org/10.1016/j.healun.2008.06.017
  11. Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation 2010;90:444-50.
  12. Young JB, Hauptman PJ, Naftel DC, et al. Determinants of early graft failure following cardiac transplantation, a 10-year, multi-institutional, multivariable analysis. J Heart Lung Transplant 2001;20:212.
  13. Tissot C, Buckvold S, Phelps CM, et al. Outcome of extracorporeal membrane oxygenation for early primary graft failure after pediatric heart transplantation. J Am Coll Cardiol 2009;54:730-7. https://doi.org/10.1016/j.jacc.2009.04.062
  14. Segovia J, Pulpon LA, Sanmartin M, et al. Primary graft failure in heart transplantation: a multivariate analysis. Transplant Proc 1998;30:1932. https://doi.org/10.1016/S0041-1345(98)00485-0
  15. Chou NK, Chi NH, Ko WJ, et al. Extracorporeal membrane oxygenation for perioperative cardiac allograft failure. ASAIO J 2006;52:100-3. https://doi.org/10.1097/01.mat.0000196514.69525.d9

Cited by

  1. Initial Report of the Korean Organ Transplant Registry (KOTRY): Heart Transplantation vol.47, pp.6, 2017, https://doi.org/10.4070/kcj.2016.0403
  2. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant vol.27, pp.2, 2014, https://doi.org/10.1093/icvts/ivy050
  3. Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes vol.23, pp.4, 2014, https://doi.org/10.1111/petr.13414
  4. Primary Graft Dysfunction After Isolated Heart Transplantation ― Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience ― vol.85, pp.9, 2021, https://doi.org/10.1253/circj.cj-20-0960